Cambridge: AstraZeneca and Sanofi s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by.
Sanofi (SNY) and AstraZeneca (AZN) announce Beyfortus approved in Japan for the prevention of RSV disease in infants streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The fall-winter COVID-19 vaccine designed to counter XBB, a subvariant of the Omicron strain, is now available nationwide for people of all ages, free of charge.
Equis secures financing for biomass power plant in Japan | Bioenergy Insight Magazine bioenergy-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioenergy-news.com Daily Mail and Mail on Sunday newspapers.
Hiroyuki Moriuchi, a professor of pediatric infectious diseases at Nagasaki University Hospital. Some Japanese municipalities are considering reviewing bans on talking during school lunchtimes, first imposed on elementary and junior high schools about two years ago to prevent coronavirus transmissions.